Hereceptin Biosimilar-China Market Status and Trend Report 2013-2023

Date: December 17, 2017
Pages: 141
Price:
US$ 2,980.00
Publisher: MIReports Co., Limited
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HFE48B1EE00EN
Leaflet:

Download PDF Leaflet

Hereceptin Biosimilar-China Market Status and Trend Report 2013-2023
Report Summary

Hereceptin Biosimilar-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hereceptin Biosimilar industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole China and Regional Market Size of Hereceptin Biosimilar 2013-2017, and development forecast 2018-2023
Main market players of Hereceptin Biosimilar in China, with company and product introduction, position in the Hereceptin Biosimilar market
Market status and development trend of Hereceptin Biosimilar by types and applications
Cost and profit status of Hereceptin Biosimilar, and marketing status
Market growth drivers and challenges

The report segments the China Hereceptin Biosimilar market as:

China Hereceptin Biosimilar Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North China
Northeast China
East China
Central & South China
Southwest China
Northwest China

China Hereceptin Biosimilar Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Tablet
Capsule

China Hereceptin Biosimilar Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Pharmaceuticals
Healthcare
Others

China Hereceptin Biosimilar Market: Players Segment Analysis (Company and Product introduction, Hereceptin Biosimilar Sales Volume, Revenue, Price and Gross Margin):

Mylan N.V.
AryoGen Biopharma
Genor Biopharma
Celltrion Inc.
Amgen Inc.
Mabion S.A.
The Instituto Vital Brazil
F. Hoffmann-La Roche AG
Biocon
Gedeon Richter Plc

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF HERECEPTIN BIOSIMILAR

1.1 Definition of Hereceptin Biosimilar in This Report
1.2 Commercial Types of Hereceptin Biosimilar
  1.2.1 Tablet
  1.2.2 Capsule
1.3 Downstream Application of Hereceptin Biosimilar
  1.3.1 Pharmaceuticals
  1.3.2 Healthcare
  1.3.3 Others
1.4 Development History of Hereceptin Biosimilar
1.5 Market Status and Trend of Hereceptin Biosimilar 2013-2023
  1.5.1 China Hereceptin Biosimilar Market Status and Trend 2013-2023
  1.5.2 Regional Hereceptin Biosimilar Market Status and Trend 2013-2023

CHAPTER 2 CHINA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Hereceptin Biosimilar in China 2013-2017
2.2 Consumption Market of Hereceptin Biosimilar in China by Regions
  2.2.1 Consumption Volume of Hereceptin Biosimilar in China by Regions
  2.2.2 Revenue of Hereceptin Biosimilar in China by Regions
2.3 Market Analysis of Hereceptin Biosimilar in China by Regions
  2.3.1 Market Analysis of Hereceptin Biosimilar in North China 2013-2017
  2.3.2 Market Analysis of Hereceptin Biosimilar in Northeast China 2013-2017
  2.3.3 Market Analysis of Hereceptin Biosimilar in East China 2013-2017
  2.3.4 Market Analysis of Hereceptin Biosimilar in Central & South China 2013-2017
  2.3.5 Market Analysis of Hereceptin Biosimilar in Southwest China 2013-2017
  2.3.6 Market Analysis of Hereceptin Biosimilar in Northwest China 2013-2017
2.4 Market Development Forecast of Hereceptin Biosimilar in China 2018-2023
  2.4.1 Market Development Forecast of Hereceptin Biosimilar in China 2018-2023
  2.4.2 Market Development Forecast of Hereceptin Biosimilar by Regions 2018-2023

CHAPTER 3 CHINA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole China Market Status by Types
  3.1.1 Consumption Volume of Hereceptin Biosimilar in China by Types
  3.1.2 Revenue of Hereceptin Biosimilar in China by Types
3.2 China Market Status by Types in Major Countries
  3.2.1 Market Status by Types in North China
  3.2.2 Market Status by Types in Northeast China
  3.2.3 Market Status by Types in East China
  3.2.4 Market Status by Types in Central & South China
  3.2.5 Market Status by Types in Southwest China
  3.2.6 Market Status by Types in Northwest China
3.3 Market Forecast of Hereceptin Biosimilar in China by Types

CHAPTER 4 CHINA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Hereceptin Biosimilar in China by Downstream Industry
4.2 Demand Volume of Hereceptin Biosimilar by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Hereceptin Biosimilar by Downstream Industry in North China
  4.2.2 Demand Volume of Hereceptin Biosimilar by Downstream Industry in Northeast China
  4.2.3 Demand Volume of Hereceptin Biosimilar by Downstream Industry in East China
  4.2.4 Demand Volume of Hereceptin Biosimilar by Downstream Industry in Central & South China
  4.2.5 Demand Volume of Hereceptin Biosimilar by Downstream Industry in Southwest China
  4.2.6 Demand Volume of Hereceptin Biosimilar by Downstream Industry in Northwest China
4.3 Market Forecast of Hereceptin Biosimilar in China by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF HERECEPTIN BIOSIMILAR

5.1 China Economy Situation and Trend Overview
5.2 Hereceptin Biosimilar Downstream Industry Situation and Trend Overview

CHAPTER 6 HERECEPTIN BIOSIMILAR MARKET COMPETITION STATUS BY MAJOR PLAYERS IN CHINA

6.1 Sales Volume of Hereceptin Biosimilar in China by Major Players
6.2 Revenue of Hereceptin Biosimilar in China by Major Players
6.3 Basic Information of Hereceptin Biosimilar by Major Players
  6.3.1 Headquarters Location and Established Time of Hereceptin Biosimilar Major Players
  6.3.2 Employees and Revenue Level of Hereceptin Biosimilar Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 HERECEPTIN BIOSIMILAR MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Mylan N.V.
  7.1.1 Company profile
  7.1.2 Representative Hereceptin Biosimilar Product
  7.1.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of Mylan N.V.
7.2 AryoGen Biopharma
  7.2.1 Company profile
  7.2.2 Representative Hereceptin Biosimilar Product
  7.2.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of AryoGen Biopharma
7.3 Genor Biopharma
  7.3.1 Company profile
  7.3.2 Representative Hereceptin Biosimilar Product
  7.3.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of Genor Biopharma
7.4 Celltrion Inc.
  7.4.1 Company profile
  7.4.2 Representative Hereceptin Biosimilar Product
  7.4.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of Celltrion Inc.
7.5 Amgen Inc.
  7.5.1 Company profile
  7.5.2 Representative Hereceptin Biosimilar Product
  7.5.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of Amgen Inc.
7.6 Mabion S.A.
  7.6.1 Company profile
  7.6.2 Representative Hereceptin Biosimilar Product
  7.6.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of Mabion S.A.
7.7 The Instituto Vital Brazil
  7.7.1 Company profile
  7.7.2 Representative Hereceptin Biosimilar Product
  7.7.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of The Instituto Vital Brazil
7.8 F. Hoffmann-La Roche AG
  7.8.1 Company profile
  7.8.2 Representative Hereceptin Biosimilar Product
  7.8.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche AG
7.9 Biocon
  7.9.1 Company profile
  7.9.2 Representative Hereceptin Biosimilar Product
  7.9.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of Biocon
7.10 Gedeon Richter Plc
  7.10.1 Company profile
  7.10.2 Representative Hereceptin Biosimilar Product
  7.10.3 Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin of Gedeon Richter Plc

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF HERECEPTIN BIOSIMILAR

8.1 Industry Chain of Hereceptin Biosimilar
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF HERECEPTIN BIOSIMILAR

9.1 Cost Structure Analysis of Hereceptin Biosimilar
9.2 Raw Materials Cost Analysis of Hereceptin Biosimilar
9.3 Labor Cost Analysis of Hereceptin Biosimilar
9.4 Manufacturing Expenses Analysis of Hereceptin Biosimilar

CHAPTER 10 MARKETING STATUS ANALYSIS OF HERECEPTIN BIOSIMILAR

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference
Skip to top


Ask Your Question

Hereceptin Biosimilar-China Market Status and Trend Report 2013-2023
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: